Total current liabilities3,201,2433,305,636Deferred income$
50,307$
,360Deferred lease liability16,28114,043Total liabilities3,367,8313,481,039Commitments and contingenciesStockholders' equity: Capital stock, $0.01 par value - shares authorized 20,000,000; 7,079,170 issued and 7,001,370 outstanding, respectively70,79270,792 Additional paid-in capital25,870,20525,787,960 Accumulated deficit(11,452,987)(10,569,045) Treasury stock, 77,800 shares(412,424)(412,424)Stockholders' equity14,075,58614,877,283Total liabilities and stockholders' equity$17,443,417$18,358,322MISONIX, INC. And SubsidiariesConsolidated Statements of OperationsUnauditedThree Months EndedSeptember 30,20112010Net sales
$3,739,156
$3,257,988Cost of goods sold
1,817,477
1,620,703Gross profit
1,921,679
1,637,285Selling expenses
1,270,407
965,007General and administrative expenses
1,167,820
1,217,805Research and development expenses
397,226
460,494Total operating expenses
2,835,453
2,643,306Operating loss from continuing operations
(913,774)
(1,006,021)Total other income
94,826
201,590Loss from continuing operations before income taxes
(818,948)
(804,431)Income tax expense
4,960
38,100Net loss from continuing operations
(823,908)
(842,531)Discontinued operations:Net loss from discontinued operations, net of income tax expense of $0 and $0, respectively
(60,034)
(175,315)Net loss from discontinued operations
(60,034)
(175,315)Net loss
($883,942)
($1,017,846)Net loss per share from continuing operations-Basic
($0.12)
($0.12)Net loss per share from discontinued operations-Basic
(0.01)
(0.03)Net loss per share-Basic
($0.13)
($0.15)Net loss per share from continuing operations-Diluted
($0.12)
($0.12)Net los
'/>"/>
SOURCE Misonix, Inc. Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related medicine technology :1.
Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern2.
Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results3.
Misonix, Inc. Announces the Sale of Sonora Medical Systems for $8 Million4.
Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland5.
Misonix Announces New Distribution Agreement for Mexico6.
Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern7.
Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries8.
Misonix Announces New Distribution Agreement for Peru9.
Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE)10.
Misonix Announces New Distribution Agreement for Argentina11.
Misonix Announces New Distribution Agreement for Kingdom of Saudi Arabia